Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
出版年份 2021 全文链接
标题
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-26
DOI
10.1007/s40257-021-00645-0
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases
- (2021) Charles Khouri et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Long‐Term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Updated Analysis With Up to 5 Years of Follow‐Up
- (2021) Richard S. Finn et al. ONCOLOGIST
- Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience
- (2021) Sumir Chawla et al. BREAST CANCER RESEARCH AND TREATMENT
- Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4/6 Inhibitors: A Systematic Review
- (2021) Martina Silvestri et al. DRUG SAFETY
- Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase (CDK) 4/6 inhibitor use
- (2021) Morgan Amigo et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Breast cancer
- (2021) Sibylle Loibl et al. LANCET
- Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System
- (2021) Emanuel Raschi et al. Cancers
- DPP-4 Inhibitors and Increased Reporting Odds of Bullous Pemphigoid: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) from 2006 to 2020
- (2021) Patrick M. Jedlowski et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption
- (2020) Shreya Patel et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
- (2020) Emanuel Raschi et al. Targeted Oncology
- Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
- (2020) Pietro Sollena et al. BREAST CANCER RESEARCH AND TREATMENT
- The value of case reports and spontaneous reporting systems for pharmacovigilance and clinical practice
- (2020) E. Raschi et al. BRITISH JOURNAL OF DERMATOLOGY
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
- (2020) David-Dan Nguyen et al. JAMA Dermatology
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- (2020) M.E. Lacouture et al. ANNALS OF ONCOLOGY
- Nail changes due to chemotherapy: a prospective observational study of 129 patients
- (2019) V. Zawar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success
- (2019) Marina Elena Cazzaniga et al. BREAST CANCER RESEARCH AND TREATMENT
- Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System
- (2019) Emanuel Raschi et al. ONCOLOGIST
- Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study
- (2019) D.M. Barrios et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
- (2019) Jennifer J Gao et al. LANCET ONCOLOGY
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- (2018) Alexandra K. Rzepecki et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Erythema multiforme major with swollen lips and crusted erosions
- (2018) Michelangelo La Placa et al. LANCET
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- (2018) Mario Lacouture et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- The value of patient reporting to the pharmacovigilance system: a systematic review
- (2016) Pedro Inácio et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now